Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-048683
Filing Date
2025-04-01
Accepted
2025-04-01 17:00:17
Documents
25
Period of Report
2025-05-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A mnkd-20250401.htm   iXBRL DEF 14A 2054471
2 GRAPHIC img31909177_0.jpg GRAPHIC 605475
3 GRAPHIC img31909177_1.jpg GRAPHIC 27243
4 GRAPHIC img31909177_2.jpg GRAPHIC 27243
5 GRAPHIC img31909177_3.jpg GRAPHIC 5041
6 GRAPHIC img31909177_4.jpg GRAPHIC 142946
7 GRAPHIC img31909177_5.jpg GRAPHIC 163675
8 GRAPHIC img31909177_6.jpg GRAPHIC 797944
9 GRAPHIC img31909177_7.jpg GRAPHIC 672695
10 GRAPHIC img31909177_8.jpg GRAPHIC 688303
11 GRAPHIC img31909177_9.jpg GRAPHIC 5041
12 GRAPHIC img31909177_10.jpg GRAPHIC 149130
13 GRAPHIC img31909177_11.jpg GRAPHIC 143649
  Complete submission text file 0000950170-25-048683.txt   11478183

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20250401.xsd EX-101.SCH 89300
27 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20250401_htm.xml XML 318775
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50865 | Film No.: 25800632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)